Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Transgenic Mice
100%
MMTV-Neu
100%
Adenocarcinoma Cells
100%
Mammary Adenocarcinoma Cells
100%
Tumor
66%
Neu Oncogene
66%
Mammary Adenocarcinoma
66%
Therapeutic Strategies
33%
Overexpression
33%
Breast Tumor
33%
Nude Mice
33%
Induced Apoptosis
33%
Histopathological Features
33%
Transformed Phenotype
33%
Mammary Gland
33%
Chromosome number
33%
Primary Tumor
33%
Chemotherapy-induced
33%
Flow Cytometric Analysis
33%
G1 Phase
33%
Life Cycle Analysis
33%
Epithelial Phenotype
33%
Novel Protocol
33%
Immunodeficient
33%
Etoposide
33%
Murine Cells
33%
Endocrine Therapy
33%
Doubling Time
33%
Plating Efficiency
33%
Clonogenic Capacity
33%
Medicine and Dentistry
Transgenic Mouse
100%
Cell Line
100%
Mouse Mammary Tumor Virus
100%
Breast Adenocarcinoma
100%
Adenocarcinoma Cell Line
100%
Neoplasm
33%
Oncogene Neu
33%
In Vitro
16%
Programmed Cell Death
16%
Breast Tumor
16%
Hormone Therapy
16%
Primary Tumor
16%
Flow Cytometry
16%
Tamoxifen
16%
Etoposide
16%
Karyotype
16%
G1 Phase
16%
Cell-Cycle Analysis
16%
Immunology and Microbiology
Transgenic Mouse
100%
Cell Line
100%
Mouse Mammary Tumor Virus
100%
Adenocarcinoma Cell Line
100%
Oncogene Neu
33%
Lineages
16%
Cell Cycle
16%
Cell Cycle G1 Phase
16%
Nude Mouse
16%
Karyotype
16%
Mammary Gland
16%
Programmed Cell Death
16%
Biochemistry, Genetics and Molecular Biology
Transgenic Mouse
100%
Mouse Mammary Tumor Virus
100%
Oncogene Neu
66%
Nude Mouse
33%
G1 Phase
33%
Karyotype
33%
Cell-Cycle Analysis
33%
Flow Cytometry
33%
Programmed Cell Death
33%